[Skip to Content]
[Skip to Content Landing]
Views 74
Citations 0
Research Letter
November 15, 2018

Use of Corticosteroid-Eluting Sinus Stents Between 2012 and 2017

Author Affiliations
  • 1Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston
  • 2Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts
  • 3Harvard Business School, Boston, Massachusetts
JAMA Otolaryngol Head Neck Surg. Published online November 15, 2018. doi:10.1001/jamaoto.2018.2944

More than 250 000 individuals undergo ambulatory endoscopic sinus surgery for chronic rhinosinusitis each year. Although estimates vary, up to one-fifth of these patients may undergo revision surgery for symptoms secondary to formation of adhesions, recurrent polyposis, and persistent inflammation.1 In an effort to limit the use of revision surgery, otolaryngologists have used postoperative adjunct treatments such as packing materials and oral corticosteroid therapy.